Skip to main content

Table 3 DFS-related DEAS events for HP GC patients

From: Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance

Gene Type ID Coef HR 95% CI P value
POLM RI 79446 2.321 10.186 2.266–45.797 0.002
PLCD1 AP 64008 − 1.566 0.209 0.057–0.771 0.019
C9orf156 AP 87024 3.492 32.849 1.576–684.536 0.024
ELMOD3 RI 54213 2.629 13.856 1.331–144.215 0.028
TCF12 ES 30789 − 6.138 0.002 0.000–0.043 0.000
SYBU AP 84909 − 4.891 0.008 0.000–0.179 0.002
ZFYVE21 ES 29513 11.239 76,054.320 322.567–17,931,942.782 0.000
  1. DFS disease-free survival, DEAS differently expressed alternative splicing, HPGC Helicobacter pylori-negative gastric cancer, RI retained intron, AP alternate promoter, ES exon skip, HR hazard ratio, CI confidence interval